Viewing Study NCT04514393


Ignite Creation Date: 2025-12-25 @ 1:09 AM
Ignite Modification Date: 2026-04-23 @ 12:44 AM
Study NCT ID: NCT04514393
Status: UNKNOWN
Last Update Posted: 2022-04-07
First Post: 2020-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
Sponsor: Huiqiang Huang
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Central Nervous System Lymphoma View
None PCNSL View
None Non Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PCNSL View
None Newly Diagnosed View